Publications found:
55,654
Sort by:
Metastatic Ovarian Cancer R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF METASTATIC OVARIAN CANCER PIPELINE REPORT INCLUDES Panorama of Metastatic Ovarian Cancer pipeline markets including statistics on therapeutic drugs and companies involved Metastatic Ovarian Cancer Pipeline candidates across various development ...
August 2018
80 pages
Microscopic Polyangiitis (MPA) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF MICROSCOPIC POLYANGIITIS (MPA) PIPELINE REPORT INCLUDES Panorama of Microscopic Polyangiitis (MPA) pipeline markets including statistics on therapeutic drugs and companies involved Microscopic Polyangiitis (MPA) Pipeline candidates across various development ...
August 2018
30 pages
Middle East Respiratory Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF MIDDLE EAST RESPIRATORY SYNDROME PIPELINE REPORT INCLUDES Panorama of Middle East Respiratory Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Middle East Respiratory Syndrome Pipeline candidates across ...
August 2018
40 pages
Mild Cognitive Impairment R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF MILD COGNITIVE IMPAIRMENT PIPELINE REPORT INCLUDES Panorama of Mild Cognitive Impairment pipeline markets including statistics on therapeutic drugs and companies involved Mild Cognitive Impairment Pipeline candidates across various development ...
August 2018
100 pages
Mucopolysaccharidosis Type II (Hunter Syndrome ) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF MUCOPOLYSACCHARIDOSIS TYPE II (HUNTER SYNDROME ) PIPELINE REPORT INCLUDES Panorama of Mucopolysaccharidosis Type II (Hunter Syndrome ) pipeline markets including statistics on therapeutic drugs and companies involved Mucopolysaccharidosis Type II (Hunter Syndrome ) Pipeline candidates across ...
August 2018
50 pages
MucopolysaccharidosisType I (Hurler Syndrome) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF MUCOPOLYSACCHARIDOSISTYPE I (HURLER SYNDROME) PIPELINE REPORT INCLUDES Panorama of MucopolysaccharidosisType I (Hurler Syndrome) pipeline markets including statistics on therapeutic drugs and companies involved MucopolysaccharidosisType I (Hurler Syndrome) Pipeline candidates across ...
August 2018
50 pages
Multiple System Atrophy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF MULTIPLE SYSTEM ATROPHY PIPELINE REPORT INCLUDES Panorama of Multiple System Atrophy pipeline markets including statistics on therapeutic drugs and companies involved Multiple System Atrophy Pipeline candidates across various development ...
August 2018
40 pages
Mumps R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF MUMPS PIPELINE REPORT INCLUDES Panorama of Mumps pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
20 pages
Muscle Atrophy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF MUSCLE ATROPHY PIPELINE REPORT INCLUDES Panorama of Muscle Atrophy pipeline markets including statistics on therapeutic drugs and companies involved Muscle Atrophy Pipeline candidates across various development ...
August 2018
30 pages
Muscle Invasive Bladder Cancer R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF MUSCLE INVASIVE BLADDER CANCER PIPELINE REPORT INCLUDES Panorama of Muscle Invasive Bladder Cancer pipeline markets including statistics on therapeutic drugs and companies involved Muscle Invasive Bladder Cancer Pipeline candidates across ...
August 2018
90 pages
Muscular Dystrophy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF MUSCULAR DYSTROPHY PIPELINE REPORT INCLUDES Panorama of Muscular Dystrophy pipeline markets including statistics on therapeutic drugs and companies involved Muscular Dystrophy Pipeline candidates across various development ...
August 2018
120 pages
Myasthenia Gravis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF MYASTHENIA GRAVIS PIPELINE REPORT INCLUDES Panorama of Myasthenia Gravis pipeline markets including statistics on therapeutic drugs and companies involved Myasthenia Gravis Pipeline candidates across various development ...
August 2018
100 pages
Myocardial Fibrosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF MYOCARDIAL FIBROSIS PIPELINE REPORT INCLUDES Panorama of Myocardial Fibrosis pipeline markets including statistics on therapeutic drugs and companies involved Myocardial Fibrosis Pipeline candidates across various development ...
August 2018
70 pages
Myocardial Ischemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF MYOCARDIAL ISCHEMIA PIPELINE REPORT INCLUDES Panorama of Myocardial Ischemia pipeline markets including statistics on therapeutic drugs and companies involved Myocardial Ischemia Pipeline candidates across various development ...
August 2018
50 pages
Myocarditis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF MYOCARDITIS PIPELINE REPORT INCLUDES Panorama of Myocarditis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Myotonic Dystrophy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF MYOTONIC DYSTROPHY PIPELINE REPORT INCLUDES Panorama of Myotonic Dystrophy pipeline markets including statistics on therapeutic drugs and companies involved Myotonic Dystrophy Pipeline candidates across various development ...
August 2018
50 pages
Narcolepsy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF NARCOLEPSY PIPELINE REPORT INCLUDES Panorama of Narcolepsy pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Nasal Polyposis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF NASAL POLYPOSIS PIPELINE REPORT INCLUDES Panorama of Nasal Polyposis pipeline markets including statistics on therapeutic drugs and companies involved Nasal Polyposis Pipeline candidates across various development ...
August 2018
40 pages
Nasal Polyps R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF NASAL POLYPS PIPELINE REPORT INCLUDES Panorama of Nasal Polyps pipeline markets including statistics on therapeutic drugs and companies involved Nasal Polyps Pipeline candidates across various development ...
August 2018
50 pages
Nasopharyngitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF NASOPHARYNGITIS PIPELINE REPORT INCLUDES Panorama of Nasopharyngitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Nephroblastoma (Wilms' Tumor) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF NEPHROBLASTOMA (WILMS' TUMOR) PIPELINE REPORT INCLUDES Panorama of Nephroblastoma (Wilms' Tumor) pipeline markets including statistics on therapeutic drugs and companies involved Nephroblastoma (Wilms' Tumor) Pipeline candidates across various development ...
August 2018
40 pages
Nephrotic Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF NEPHROTIC SYNDROME PIPELINE REPORT INCLUDES Panorama of Nephrotic Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Nephrotic Syndrome Pipeline candidates across various development ...
August 2018
40 pages
Neurofibromatoses (Type II) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF NEUROFIBROMATOSES (TYPE II) PIPELINE REPORT INCLUDES Panorama of Neurofibromatoses (Type II) pipeline markets including statistics on therapeutic drugs and companies involved Neurofibromatoses (Type II) Pipeline candidates across various development ...
August 2018
40 pages
Neurofibromatoses R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF NEUROFIBROMATOSES PIPELINE REPORT INCLUDES Panorama of Neurofibromatoses pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Neurofibromatoses(Type I) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF NEUROFIBROMATOSES(TYPE I) PIPELINE REPORT INCLUDES Panorama of Neurofibromatoses(Type I) pipeline markets including statistics on therapeutic drugs and companies involved Neurofibromatoses(Type I) Pipeline candidates across various development ...
August 2018
40 pages
Neuromyelitis Optica R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF NEUROMYELITIS OPTICA PIPELINE REPORT INCLUDES Panorama of Neuromyelitis Optica pipeline markets including statistics on therapeutic drugs and companies involved Neuromyelitis Optica Pipeline candidates across various development ...
August 2018
80 pages
Neutropenia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF NEUTROPENIA PIPELINE REPORT INCLUDES Panorama of Neutropenia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
80 pages
Nicotine Addiction R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF NICOTINE ADDICTION PIPELINE REPORT INCLUDES Panorama of Nicotine Addiction pipeline markets including statistics on therapeutic drugs and companies involved Nicotine Addiction Pipeline candidates across various development ...
August 2018
50 pages
Nocturia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF NOCTURIA PIPELINE REPORT INCLUDES Panorama of Nocturia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
20 pages
Non Muscle Invasive Bladder Cancer R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF NON MUSCLE INVASIVE BLADDER CANCER PIPELINE REPORT INCLUDES Panorama of Non Muscle Invasive Bladder Cancer pipeline markets including statistics on therapeutic drugs and companies involved Non Muscle Invasive Bladder Cancer Pipeline candidates across ...
August 2018
150 pages
Obsessive Compulsive Disorder R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF OBSESSIVE COMPULSIVE DISORDER PIPELINE REPORT INCLUDES Panorama of Obsessive Compulsive Disorder pipeline markets including statistics on therapeutic drugs and companies involved Obsessive Compulsive Disorder Pipeline candidates across various development ...
August 2018
30 pages
Obstructive Sleep Apnea R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF OBSTRUCTIVE SLEEP APNEA PIPELINE REPORT INCLUDES Panorama of Obstructive Sleep Apnea pipeline markets including statistics on therapeutic drugs and companies involved Obstructive Sleep Apnea Pipeline candidates across various development ...
August 2018
40 pages
Ocular Hypertension R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF OCULAR HYPERTENSION PIPELINE REPORT INCLUDES Panorama of Ocular Hypertension pipeline markets including statistics on therapeutic drugs and companies involved Ocular Hypertension Pipeline candidates across various development ...
August 2018
100 pages
Ocular Pain R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF OCULAR PAIN PIPELINE REPORT INCLUDES Panorama of Ocular Pain pipeline markets including statistics on therapeutic drugs and companies involved Ocular Pain Pipeline candidates across various development ...
August 2018
60 pages
Oligodendroglioma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF OLIGODENDROGLIOMA PIPELINE REPORT INCLUDES Panorama of Oligodendroglioma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
120 pages
Onychomycosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF ONYCHOMYCOSIS PIPELINE REPORT INCLUDES Panorama of Onychomycosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Opioid Induced Bowel Dysfunction R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF OPIOID INDUCED BOWEL DYSFUNCTION PIPELINE REPORT INCLUDES Panorama of Opioid Induced Bowel Dysfunction pipeline markets including statistics on therapeutic drugs and companies involved Opioid Induced Bowel Dysfunction Pipeline candidates across ...
August 2018
20 pages
Opioid Induced Constipation (OIC) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF OPIOID INDUCED CONSTIPATION (OIC) PIPELINE REPORT INCLUDES Panorama of Opioid Induced Constipation (OIC) pipeline markets including statistics on therapeutic drugs and companies involved Opioid Induced Constipation (OIC) Pipeline candidates across ...
August 2018
50 pages
Opium Addiction R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF OPIUM ADDICTION PIPELINE REPORT INCLUDES Panorama of Opium Addiction pipeline markets including statistics on therapeutic drugs and companies involved Opium Addiction Pipeline candidates across various development ...
August 2018
90 pages
Optic Neuritis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF OPTIC NEURITIS PIPELINE REPORT INCLUDES Panorama of Optic Neuritis pipeline markets including statistics on therapeutic drugs and companies involved Optic Neuritis Pipeline candidates across various development ...
August 2018
40 pages
Optic Neuropathy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF OPTIC NEUROPATHY PIPELINE REPORT INCLUDES Panorama of Optic Neuropathy pipeline markets including statistics on therapeutic drugs and companies involved Optic Neuropathy Pipeline candidates across various development ...
August 2018
50 pages
Oral Mucositis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ORAL MUCOSITIS PIPELINE REPORT INCLUDES Panorama of Oral Mucositis pipeline markets including statistics on therapeutic drugs and companies involved Oral Mucositis Pipeline candidates across various development ...
August 2018
80 pages
Ornithine Transcarbamylase Deficiency R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY PIPELINE REPORT INCLUDES Panorama of Ornithine Transcarbamylase Deficiency pipeline markets including statistics on therapeutic drugs and companies involved Ornithine Transcarbamylase Deficiency Pipeline candidates across various development ...
August 2018
30 pages
Oropharyngeal Cancer R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF OROPHARYNGEAL CANCER PIPELINE REPORT INCLUDES Panorama of Oropharyngeal Cancer pipeline markets including statistics on therapeutic drugs and companies involved Oropharyngeal Cancer Pipeline candidates across various development ...
August 2018
210 pages
Osteogenesis Imperfecta R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF OSTEOGENESIS IMPERFECTA PIPELINE REPORT INCLUDES Panorama of Osteogenesis Imperfecta pipeline markets including statistics on therapeutic drugs and companies involved Osteogenesis Imperfecta Pipeline candidates across various development ...
August 2018
40 pages
Osteomyelitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF OSTEOMYELITIS PIPELINE REPORT INCLUDES Panorama of Osteomyelitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Osteonecrosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF OSTEONECROSIS PIPELINE REPORT INCLUDES Panorama of Osteonecrosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Otitis Media R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF OTITIS MEDIA PIPELINE REPORT INCLUDES Panorama of Otitis Media pipeline markets including statistics on therapeutic drugs and companies involved Otitis Media Pipeline candidates across various development ...
August 2018
60 pages
